Clinical Study
Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients
Table 4
Outcome.
| |||||||||||||||||||||||||||||||||||
Results are given as median (minimum–maximum) or numbers (percentages). Groups were compared with Fisher’s exact test or the Mann-Whitney test, as appropriate. |